Increased I-FABP levels have been demonstrated in intestinal ischemia [39], celiac disease [40], necrotizing enterocolitis [41], and is hence a potential marker of intestinal injury and increased barrier permeability. This evidence concerns the gene FABP2 and necrotizing enterocolitis.